Page 6 of 9 – SEC Filing
Item 1(a). Name of Issuer: Dynavax Technologies Corporation Item 1(b). Address of Issuers Principal Executive Offices: 2929 Seventh Street, Suite 100 Berkeley, CA 94710 Item 2(a). Name of Person Filing: Glenhill Advisors, LLC, Glenn J. Krevlin, Glenhill Capital Advisors, LLC and Glenhill Capital Management, LLC. Glenn J. Krevlin, is the managing member and control person of Glenhill Advisors, LLC, and is the sole shareholder of Krevlin Management,
Inc. Krevlin Management, Inc. is the managing member of Glenhill Capital Advisors, LLC, which is the investment manager of Glenhill Capital Overseas Master Fund, LP and Glenhill Long Fund, LP, each (along with Mr. Krevlin) a security holder of the
Issuer. Glenhill Advisors, LLC is the managing member of Glenhill Capital Management, LLC. Glenhill Capital Management, LLC is the managing member of Glenhill Long GP, LLC, and is sole shareholder of Glenhill Capital Overseas GP, Ltd. Glenhill
Capital Overseas GP, Ltd. is general partner of Glenhill Capital Overseas Master Fund, LP. Glenhill Long GP, LLC is the general partner of Glenhill Long Fund, LP.
Glenhill Capital Advisors, LLC is also the investment manager for certain third party accounts for which shares of the Issuer are held and managed by one or
more of the Reporting Persons for the benefit of such third parties. Such Reporting Persons have dispositive power and share certain voting power with respect to such shares, and receive management fees and performance-related fees in connection
therewith. As of the date of this filing, there are 560,899 shares of Common Stock of the Issuer held in such third party managed accounts, and the securities reported on the attached cover page(s) include such shares.
Item 2(b). Address of Principal Business Office or, if none, Residence: 600 Fifth Avenue, 11th Floor New York, NY 10020 Item 2(c). Citizenship: See the response(s) to Item 4 on the attached cover page(s). Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 268158201
| Item 1(a). | Name of Issuer: | |
| Dynavax Technologies Corporation | ||
| Item 1(b). | Address of Issuers Principal Executive Offices: | |
| 2929 Seventh Street, Suite 100 | ||
| Berkeley, CA 94710 | ||
| Item 2(a). | Name of Person Filing: | |
| Glenhill Advisors, LLC, Glenn J. Krevlin, Glenhill Capital Advisors, LLC and Glenhill Capital Management, LLC. | ||
| Glenn J. Krevlin, is the managing member and control person of Glenhill Advisors, LLC, and is the sole shareholder of Krevlin Management, Glenhill Capital Advisors, LLC is also the investment manager for certain third party accounts for which shares of the Issuer are held and managed by one or | ||
| Item 2(b). | Address of Principal Business Office or, if none, Residence: | |
| 600 Fifth Avenue, 11th Floor | ||
| New York, NY 10020 | ||
| Item 2(c). | Citizenship: | |
| See the response(s) to Item 4 on the attached cover page(s). | ||
| Item 2(d). | Title of Class of Securities: | |
| Common Stock | ||
| Item 2(e). | CUSIP Number: | |
| 268158201 | ||
